Author: GlobeNewswire

ROCKVILLE, MD, July 08, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative…

Urges stockholders to vote “FOR” Radius’ highly qualified, independent director nominees – Catherine J. Friedman, Jean-Pierre Garnier, Ph.D. and Andrew…

SAN FRANCISCO, July 07, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein…

OXFORD, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the…

PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics” or the “Company”), a women’s…

TAIPEI, Taiwan, July 05, 2022 (GLOBE NEWSWIRE) — OBI Pharma, a Taiwan biopharma company (TPEx: 4174), today announced discontinuation of…

SEATTLE, July 05, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development…

In-Person KOL Breakfast Meeting to be held on Tuesday, July 12th in New York CityYAVNE, Israel, July 05, 2022 (GLOBE…

WESTLAKE VILLAGE, Calif., July 05, 2022 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing…

Live Conference Call and Webcast on Wednesday, July 6, 2022, at 8:30 a.m. ET (5:30 a.m. PT)SOUTH SAN FRANCISCO, Calif.,…